Meme stocks have been rallying and it's still not too late to join the party. Attractive stocks from several sectors are yet to participate in the meme frenzy.
Planet 13's target price is lowered by analysts, but the rating is raised to Buy. The analyst's estimates for 2025 revenue and adjusted EBITDA are higher than the author's previous outlook. PLNH's valuation is cheap compared to its projected adjusted EBITDA, with a debt-free balance sheet.
Rescheduling cannabis down to a less serious classification would mean significant tax savings for multi-state marijuana operators. Three of the largest cannabis companies in the U.S. today are Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis.
Despite the recent lackluster performance, cannabis stocks shouldn't be overlooked. With ongoing legalization efforts in the U.S. and promising research into the plant's health benefits, the potential for significant returns is immense.
The number of daily cannabis users has increased by a stunning twentyfold since 1992. As cannabis becomes more mainstream, industries and politicians won't be able to ignore it.
Cannabis and related products seller Tilray Brands (NASDAQ: TLRY ) is headquartered in Canada. However, the company seeks to expand its presence in the U.S. if/when cannabis is legally rescheduled there.
Investing in cannabis Real Estate Investment Trusts (REITs) offers a lucrative opportunity as the US cannabis industry and top marijuana stocks thrive. The industry is projected to grow from $20 billion in 2020 to $100 billion by 2030. This impressive growth presents a compelling case for long-term investment in high dividend-yielding stocks. Cannabis REITs like Innovative Industrial Properties, Inc. (IIPR), NewLake Capital Partners, Inc. (NLCP), and AFC Gamma, Inc. (AFCG) are at the forefront, providing robust dividends and growth potential. Furthermore, recent headlines hint at possible federal legalization, which could significantly boost the sector's prospects. With the increasing acceptance and legalization of cannabis across states, these REITs are well-positioned for substantial returns.
Undervalued cannabis stocks may be some of the most controversial trades on the market. But they've also proven themselves to be some of the most profitable.
As the cannabis industry continues to grow, investors are closely watching top Canadian marijuana stocks this week. The global cannabis market is projected to reach $73.6 billion by 2027, with the U.S. market accounting for a significant portion. Recent news about potential federal legalization in the U.S. has fueled optimism. This could open up new opportunities for Canadian cannabis companies. With increasing demand for both medical and recreational cannabis, these companies are strategically positioned for growth. Investors should pay attention to market trends and developments. Using technical analysis can help identify buying opportunities and trends. Additionally, proper risk management is crucial to navigating this volatile market.
SALT LAKE CITY, UT / ACCESSWIRE / June 4, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or "the Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced that Tim Pickett, Founder and Chief Executive Officer, is scheduled to present at the KCSA Cannabis Virtual Conference on Wednesday, June 5th at 3 p.m. ET. Registration Link: Click Here If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available.
Chicago Atlantic Real Estate Finance is a lender to US cannabis operators with total loan commitments of roughly $401.3 million. REFI is currently trading at an 8.4x multiple to annualized first-quarter EPS and a small 4.9% premium to its book value. The uncertainty for REFI shareholders is whether the current dividend faces a near-term reduction with the payout running at 100% against EPS.
The cannabis industry and marijuana stocks in the United States are booming, with recent reports projecting the market to exceed $40 billion by 2025. Ancillary cannabis companies, which provide essential products and services to growers and retailers, play a crucial role in this growth. These companies supply everything from hydroponic equipment to real estate, ensuring the industry runs smoothly. Notably, recent headlines about potential federal legalization have sparked investor interest. This legal shift could open up significant opportunities for ancillary businesses, making them attractive investments.